These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 26768079)

  • 1. Hot topics on diabetes in China.
    Weng J; Pozzilli P
    Diabetes Metab Res Rev; 2015 Nov; 31(8):779-80. PubMed ID: 26768079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes Metabolism: Research and Reviews--Chinese Diabetes Society special issue: a small but encouraging step toward the successful control of diabetes in China.
    Weng J; Pozzilli P
    Diabetes Metab Res Rev; 2014 Sep; 30(6):445-6. PubMed ID: 25044807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A thorough analysis of diabetes research in China from 1995 to 2015: current scenario and future scope.
    Wu Z; Jin T; Weng J
    Sci China Life Sci; 2019 Jan; 62(1):46-62. PubMed ID: 30267261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individualized exercise training prescription for patients with type 2 diabetes mellitus.
    Chang CQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Jun; 33(3):248-52. PubMed ID: 21718604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why China guidelines for type 2 diabetes represent an opportunity for treating this disease.
    Maddaloni E; Pozzilli P
    Diabetes Metab Res Rev; 2016 Jul; 32(5):438-9. PubMed ID: 27464263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring practice characteristics and research priorities of practitioners of traditional acupuncture in China and the EU-A survey.
    Robinson N; Lorenc A; Ding W; Jia J; Bovey M; Wang XM
    J Ethnopharmacol; 2012 Apr; 140(3):604-13. PubMed ID: 22338645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hot topics in Chinese herbal drugs research documented in PubMed/MEDLINE by authors inside China and outside of China in the past 10 years: based on co-word cluster analysis.
    Li HY; Cui L; Cui M
    J Altern Complement Med; 2009 Jul; 15(7):779-85. PubMed ID: 19534611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in diabetes research in China.
    Ning G; Hong J; Bi Y; Gu W; Zhang Y; Zhang Z; Huang Y; Wang W; Li X
    J Diabetes; 2009 Sep; 1(3):163-72. PubMed ID: 20923535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of diabetes using traditional Chinese medicine: past, present and future.
    Tong XL; Dong L; Chen L; Zhen Z
    Am J Chin Med; 2012; 40(5):877-86. PubMed ID: 22928822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International standards and guidelines on education and training for the multi-disciplinary health response to major events that threaten the health status of a community.
    Seynaeve G; Archer F; Fisher J; Lueger-Schuster B; Rowlands A; Sellwood P; Vandevelde K; Zigoura A;
    Prehosp Disaster Med; 2004; 19(2):S17-30. PubMed ID: 15506258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 2 diabetes in China: partnerships in education and research to evaluate new antidiabetic treatments.
    Donnelly R; Wang B; Qu X
    Br J Clin Pharmacol; 2006 Jun; 61(6):702-5. PubMed ID: 16722832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of switching to biphasic insulin aspart in poorly-controlled type 2 diabetes patients in China.
    Palmer JL; Gibbs M; Scheijbeler HW; Kotchie RW; Nielsen S; White J; Valentine WJ
    Adv Ther; 2008 Aug; 25(8):752-74. PubMed ID: 18704282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Traditional Chinese medicine research in the post-genomic era: good practice, priorities, challenges and opportunities.
    Uzuner H; Bauer R; Fan TP; Guo DA; Dias A; El-Nezami H; Efferth T; Williamson EM; Heinrich M; Robinson N; Hylands PJ; Hendry BM; Cheng YC; Xu Q
    J Ethnopharmacol; 2012 Apr; 140(3):458-68. PubMed ID: 22387462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory bowel disease in the 21(st) century in China: turning challenges into opportunities.
    Ouyang Q; Xue LY
    J Dig Dis; 2012 Apr; 13(4):195-9. PubMed ID: 22435503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visualization studies on evidence-based medicine domain knowledge (series 1): mapping of evidence-based medicine research subjects.
    Shen J; Yao L; Li Y; Clarke M; Gan Q; Fan Y; Zhong D; Li Y; Gou Y; Wang L
    J Evid Based Med; 2011 May; 4(2):73-84. PubMed ID: 23672698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioethics in China.
    Li EC
    Bioethics; 2008 Sep; 22(8):448-54. PubMed ID: 18410463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing contribution of China in modern biomedical research. Statistical data from ISI Web of Knowledge.
    Makris GC; Spanos A; Rafailidis PI; Falagas ME
    Med Sci Monit; 2009 Dec; 15(12):SR15-21. PubMed ID: 19946247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basic research on inflammatory bowel disease in China.
    Bai AP; Ouyang Q; Hu RW
    J Dig Dis; 2007 Nov; 8(4):194-7. PubMed ID: 17970875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost-effectiveness analysis of JinQi Jiangtang tablets for the treatment on prediabetes: a randomized, double-blind, placebo-controlled, multicenter design.
    Sun X; Guo L; Shang H; Ren M; Wang Y; Huo D; Lei X; Wang H; Zhai J
    Trials; 2015 Nov; 16():496. PubMed ID: 26530718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.